# Patent Analysis — Echelon Cognitive Pipeline

**Agent**: ORACLE (IP/Patent Specialist)
**Date**: 2026-04-02
**Run ID**: squad-1775164062
**Status**: Deliverable for IP Strategy Review

---

## Section 1: Prior Art Landscape

### NOVEL-001: Endocrine Neuromodulation System

**Frameworks surveyed**: LangChain, CrewAI, AutoGen, LlamaIndex, Microsoft Semantic Kernel, Stanford DSPy, MetaGPT

**State of prior art**: No framework implements dynamic hormone-like scalars tied to phase state. CrewAI has static text personas; AutoGen and LangChain have no personality system. Closest prior art: simulation literature (Ayouni et al. 2020) on agent personality — but static, not dynamically modulated.

**Echelon's distinguishing delta**:
- 6-parameter neuroendocrine state vector per agent (`scripts/bash/endocrine.sh` lines 83-93)
- Phase-gated event triggers (adrenaline +0.25 on deadline, dopamine +0.15 on gate pass)
- Exponential decay per hormone (adrenaline 0.6×/cycle, serotonin 0.95×/cycle)
- 30% downstream propagation across agent hops
- Circuit breakers: ±0.4 max delta/cycle, [0.0, 1.0] clamp

**Invalidation risk**: MEDIUM. Concept of personality exists in simulation; novelty is the **real-time quantified dynamics**, not the existence of personality.

---

### NOVEL-003: NS-003 Generator-Critic + AGM Belief Revision

**Frameworks surveyed**: Same as above, plus constraint-satisfaction literature

**State of prior art**: NL2GenSym (arxiv:2510.09355) proves Generator-Critic for code generation (86%+ compliance). Kumiho (arxiv:2603.17244) proves AGM belief revision for agent memory (93.3% accuracy). **Both components proven independently. Combination has zero prior literature** (U-015-002 systematic search, 8 query variants, 2026-04-02).

**Echelon's distinguishing delta**: Execution-grounded schema validation + AGM minimal contractions/revisions applied to multi-agent artifact store (spec.md, plan.md, tasks.md, data-model.md). Contradictions surfaced at write-time, not during expensive BUILD.

**Invalidation risk**: LOW-MEDIUM. Novelty of combination confirmed. Risk: competitor uses non-AGM contradiction detection (string diff, semantic hashing).

---

### NOVEL-002: Belief Annotation System

**Frameworks surveyed**: Same + OWL/RDF semantic web

**State of prior art**: LangChain has conversation memory (no temporal metadata). OWL/RDF have metadata but not integrated into LLM agent dispatch. No framework implements belief freshness classification in agent context injection.

**Echelon's distinguishing delta**: YAML @belief() annotations with `verified`, `expires`, `confidence` fields. Automated freshness classification: expired | approaching_expiry | low_confidence | fresh (`scripts/belief-parser.py` lines 43-68). Machine-readable config-belief-graph.json output.

**Invalidation risk**: MEDIUM. Straightforward mechanism; vulnerable to substitution by alternative annotation formats.

---

### NOVEL-006: Pre-Dispatch Constitutional Gate

**Frameworks surveyed**: Same + Guardrails AI, Constitutional AI (Brock et al. 2023)

**State of prior art**: Guardrails AI: post-hoc validation. Constitutional AI: guides model training, not agent dispatch. Enterprise audit: logs post-action. No framework has synchronous pre-dispatch governance with three-tier enforcement.

**Echelon's distinguishing delta**: FLAG/CONSULT/BLOCK enforcement at dispatch time. COMMANDER waits synchronously for human response on CONSULT. constitution.md is machine-readable and immutable.

**Invalidation risk**: MEDIUM-HIGH. Pre-dispatch governance is straightforward once conceived.

---

## Section 2: Claim Specificity Analysis

### CLAIM-001: NS-003 (HIGH DEFENSIBILITY)

**Narrow defensible claim**: "A method for validating and revising outputs of multi-stage LLM agent pipelines, comprising: (1) execution-grounded schema validation where a Critic LLM validates each stage output against a deterministic Echelon artifact protocol (JSON schema defining required fields for 6 artifact categories across DISCOVER, ASSESS, HOW, PLAN, BUILD, LEARN tiers); and (2) Alchourrón-Gärdenfors-Makinson belief revision logic that resolves contradictions between sequential stages by computing AGM-compliant minimal contractions or revisions, enforcing AGM consistency postulates (Success, Consistency, Relevance, Vacuity), with confidence scoring (0.5–0.95) per contradiction type."

**Evidence**: arxiv:2510.09355 (NL2GenSym), arxiv:2603.17244 (Kumiho), U-015-002-novelty-search.md (zero prior literature), `scripts/contradiction-scanner.py` (PIPELINE_STAGES lines 42-49, ARTIFACT_STAGE_MAP lines 52-80)

**Weakest point**: Components (Generator-Critic, AGM) are prior art individually. Competitor could implement non-AGM contradiction detection.

**Prototype required**: YES — REQ-015-006 (≥0.70 first-pass compliance, ≥0.80 catch rate, N=30 invocations)

---

### CLAIM-002: Endocrine Neuromodulation (HIGH DEFENSIBILITY)

**Narrow defensible claim**: "A method for modulating language model agent behavior via quantified neuromodulator-inspired state vectors, where each of six vector dimensions represents a discrete motivational axis (urgency, reward-seeking, threat-detection, mood-stability, collaboration-drive, focus-precision), characterized by: (a) per-archetype baseline initialization [e.g., exploration: 0.3, 0.7, 0.3, 0.6, 0.5, 0.4]; (b) phase-gated event-triggered delta updates; (c) exponential time-decay per dimension (adrenaline 0.6×/cycle, serotonin 0.95×); (d) downstream propagation at 0.30 attenuation ratio; (e) circuit breaker logic capping max change at ±0.4 per cycle with floor 0.0 and ceiling 1.0."

**Evidence**: `scripts/bash/endocrine.sh` (lines 83-93 hormone constants, phase triggers), `squad-config.yml` (per-archetype baselines, decay rates, circuit breakers)

**Weakest point**: "Personality in agents" exists in simulation literature. Novelty is real-time quantified dynamics, not the concept.

**Prototype required**: YES — A-005/U-005 efficacy experiment (N=10+ runs, hormones on vs. frozen)

---

### CLAIM-003: Pre-Dispatch Constitutional Governance (MEDIUM-HIGH DEFENSIBILITY)

**Narrow defensible claim**: "A method for enforcing governance principles in multi-agent LLM systems comprising: (1) human-authored constitution document defining immutable principles in machine-readable format; (2) synchronous pre-dispatch check by orchestrator validating proposed agent action against constitution principles; (3) three-tier enforcement (FLAG: log and proceed; CONSULT: await human approval before dispatch; BLOCK: refuse and escalate) with deterministic escalation protocol."

**Evidence**: `agents/control/commander.md` (pre-dispatch gate section), `.specify/memory/constitution.md` (created 2026-04-02, resolves IS-001)

**Weakest point**: Governance patterns are well-known. Pre-dispatch application is straightforward once conceived.

**Prototype required**: YES — N=20+ intentional violation tests, target ≥80% catch rate

---

## Section 3: Combination Claims

**Endocrine + Constitutional Gate**: "Personality modulation (6-hormone state vectors) combined with constitutional pre-dispatch governance (FLAG/CONSULT/BLOCK), where endocrine state influences gate-severity decisions (high cortisol/adrenaline → stricter CONSULT gates; relaxed state → FLAG gates)." — Defensibility: MEDIUM-HIGH

**Belief Freshness + Calibration Injection**: "Temporal belief freshness tracking (expired/approaching-expiry/low-confidence/fresh classification) combined with historical calibration data injection, where stale/low-confidence beliefs trigger higher calibration multipliers." — Defensibility: MEDIUM

**Formal Cognitive Role Ontology** (MAVERICK finding): "Per-tier endocrine baselines + model assignments + NEVER rules = formal cognitive role semantics with deterministically verifiable compliance." — Defensibility: HIGH (structure hard to copy, compliance is measurable)

---

## Section 4: IP Priority Matrix

| Rank | Mechanism | Claim Type | Filing Priority | Key Risk | Time to Defensibility |
|------|-----------|------------|-----------------|----------|-----------------------|
| 1 | NS-003 Generator-Critic + AGM | Combination | **IMMEDIATE** | Prototype not yet built | 3-6 months |
| 2 | Endocrine Neuromodulation | Process + Implementation | **HIGH** | Efficacy unvalidated | 6-12 months |
| 3 | Constitutional Pre-Dispatch Gate | Process + System | **HIGH** | constitution.md just created | 3-6 months |
| 4 | Formal Cognitive Role Ontology | Architectural | **MEDIUM** | Quality improvement unmeasured | 6-12 months |
| 5 | Belief Freshness + Calibration | Combination | **MEDIUM** | Impact unvalidated | 6-9 months |
| 6 | RADAR Monitoring | Technical Implementation | **LOW** | Components well-known | — |

---

## Section 5: What NOT to File

- **40-70% token reduction** (NOVEL-004): SPECULATION per P-005. No measurement, no baseline. DO NOT CLAIM. Requires N≥50 prototype runs.
- **CA mechanisms** (NOVEL-010): GATE_BLOCKED per P-006. U-CA-004 must resolve POSITIVE first.
- **Contradiction scanner** (NOVEL-012): Elementary heuristics (3 patterns). Obvious alternatives. Do not file independently.
- **7-Tier count**: Tier concept is defensible; the number 7 is not. File only if comparative benchmark proves ≥10% quality improvement vs. polymath baseline.

---

## Section 6: NS-003 Specific Claim — Full Text

**Problem**: Multi-stage LLM pipelines produce contradictory artifacts (DISCOVER stage asserts requirement X; ASSESS stage asserts incompatible constraint Y). Contradictions discovered during BUILD cause expensive rework. No framework detects contradictions at write-time.

**Claim Language**:
"A method for validating and revising outputs of multi-stage language model agent pipelines, comprising:

(A) Execution-grounded schema validation: a Critic LLM validates each stage output against a deterministic artifact protocol specifying required fields, types, and constraints for six artifact categories (DISCOVER-class: assumptions.md, glossary.md, mental-model.md; ASSESS-class: feasibility.md, estimates.md, risks.md; HOW-class: spec.md, data-model.md, test-strategy.md; PLAN-class: tasks.md, plan.md; BUILD-class: code artifacts; LEARN-class: reflection artifacts);

(B) AGM doxastic logic belief revision: contradictions between sequential stage outputs resolved via AGM-compliant minimal contractions (removing minimal prior-stage beliefs) or revisions (expanding belief set), enforcing AGM postulates (Success, Consistency, Relevance, Vacuity);

(C) Contradiction classification and confidence scoring: categorized by type (assertion conflict, scope conflict, architecture conflict) with confidence score 0.5–0.95;

(D) Real-time reporting to orchestrator: recommended action (accept new stage, revert, escalate) enabling contradiction detection before expensive BUILD-phase rework."

**Why defensible**: Combination of (A) execution-grounded Critic + (B) AGM revision + (C) typed contradiction classification applied to multi-agent artifact stores has zero prior literature (U-015-002 systematic search, 2026-04-02). Component-level proofs: NL2GenSym 86%+ (arxiv:2510.09355), Kumiho 93.3% (arxiv:2603.17244).

**Filing prerequisite**: REQ-015-006 prototype experiment — achieve ≥0.70 first-pass schema compliance + ≥0.80 contradiction catch rate + ≤0.20 false positive rate on labeled artifact pairs (N=30 Echelon invocations). Estimated: 3-6 months.
